Age related macular degeneration (AMD)

Early AMD - with low, medium or high risk of progression. Usually not a/w visual disturbances Late AMD:

  • Dry - well defined areas of atrophy of retinal pigment epithelium, drusen pigment changes 90% of cases. Has a chance to progress into wet AMD
  • Wet - characterised by choroidal neovascularisation, 10% of total AMD cases

Causes/Factors

Symptoms

  • Distortion of vision, where straight lines appear crooked or wavy.
  • Painless loss, or blurring, of central or near-central vision.
  • A black or grey patch affecting the central field of vision (scotoma).
  • Difficulty reading, driving, or seeing fine detail (such as facial features). 
  • Flickering or flashing lights (photopsia). 
  • Difficulty adjusting from bright to dim lighting.
  • Visual hallucinations (associated with severe visual loss).
  • Visual distortions - straight lines may appear wavy or bent

Signs

  • Drusen - collections of lipid material that accumulate beneath the retinal pigment epithelium (RPE) and within Brunch’s membrane

  • Retinal pigment epithelial changes

  • Geographic atrophy

  • Choroidal neovascularisation - abnormal blood vessel growth beneath the retina in wet macular degeneration

Investigations

  • Retinal exam - dilated fundus exam
  • Optical coherence tomography (OCT) high resolution imaging to assess retinal thickness and integrity
  • Fluorescein angiography - to detect choroidal neovasculatisation in wet macular degeneration

Management

Dry AMD

  • Not much is usually done
  • Lifestyle factors stop smoking & controlling blood pressure
  • Some studies have shown vitamin supplementation to be effective

Wet AMD

  • To try and prevent neovascularization, anti-VEGF (vascular endothelial growth factor) can be injected in the vitreous about once a month

Complications/red Flags

  • Visual impairment and blindness. 
  • Visual hallucinations.
  • Depression.
  • Falls and fractures.
  • Reduced quality of life